Delivery Order SPE2DB20D3505-SPE2DB25FV1L0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 per unit, with a ceiling value of $2,435.67. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 11, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a ceiling value of $2,275.62. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Azathioprine 50 mg tablets (100-count) under a firm fixed-price contract valued at $3,469.06. This is a non-set-aside award issued as a child delivery order, with performance at the contractor's Conshohocken, Pennsylvania facility and an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a ceiling value of $2,056.22. This non-competitive, firm fixed-price delivery order is set to be completed by August 4, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $4,451.80 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,187.99 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Azathioprine 50 mg tablets (100 count) with a ceiling value of $1,780.72. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a routine pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,905.81 for Azathioprine 50 mg tablets (100-count units) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract employs firm fixed pricing and represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $13,018.60 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units. This is a firm fixed price contract with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery...
- This federal contract award is for the delivery of 4,557,866 units of Azathioprine 50 mg tablets (100 count) to the Defense Logistics Agency (DLA). The $6,172.04 firm-fixed-price delivery order was awarded on July 21, 2022 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 22, 2022 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV1L0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units, with a ceiling value of $1,109.30. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (contract SPE2DX), valid through December 2026, which serves as a global pharmaceutical support vehicle enabling supply of a broad range of medications and medical supplies to military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical needs across multiple therapeutic domains through competitively awarded, firm fixed price delivery orders for both brand-name and generic medications, vaccines, and related medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/7/25 |